Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
OBLN

Obalon Therapeutics

$2.09

0.04 (1.95%)

08:28
02/26/19
02/26
08:28
02/26/19
08:28
Downgrade
Obalon Therapeutics rating change at Roth Capital »

Obalon Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    May

OBLN

Obalon Therapeutics

$2.05

-0.12 (-5.53%)

06:18
02/25/19
02/25
06:18
02/25/19
06:18
Upgrade
Obalon Therapeutics rating change at Stifel »

Obalon Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    May

OBLN

Obalon Therapeutics

$2.17

0.07 (3.33%)

08:29
02/22/19
02/22
08:29
02/22/19
08:29
Hot Stocks
Obalon Therapeutics announces first commercial shipment of navigation system »

Obalon Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 18

    May

OBLN

Obalon Therapeutics

$2.17

0.07 (3.33%)

08:03
02/22/19
02/22
08:03
02/22/19
08:03
Earnings
Obalon Therapeutics reports Q4 EPS (39c), consensus (36c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 18

    May

Over a month ago
OBLN

Obalon Therapeutics

$1.84

-0.01 (-0.54%)

16:16
02/11/19
02/11
16:16
02/11/19
16:16
Syndicate
Breaking Syndicate news story on Obalon Therapeutics »

Obalon Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    May

OBLN

Obalon Therapeutics

$1.83

(0.00%)

, APEN

Apollo Endosurgery

$3.28

-0.27 (-7.61%)

14:15
01/14/19
01/14
14:15
01/14/19
14:15
Conference/Events
Piper Jaffray medical devices analyst to hold analyst/industry conference call »

Medical Devices Analyst…

OBLN

Obalon Therapeutics

$1.83

(0.00%)

APEN

Apollo Endosurgery

$3.28

-0.27 (-7.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jan

  • 18

    May

OBLN

Obalon Therapeutics

$1.82

-0.01 (-0.55%)

, APEN

Apollo Endosurgery

$3.26

-0.29 (-8.17%)

10:43
01/14/19
01/14
10:43
01/14/19
10:43
Conference/Events
Piper Jaffray medical devices analyst to hold analyst/industry conference call »

Medical Devices Analyst…

OBLN

Obalon Therapeutics

$1.82

-0.01 (-0.55%)

APEN

Apollo Endosurgery

$3.26

-0.29 (-8.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    May

OBLN

Obalon Therapeutics

$1.90

-0.03 (-1.55%)

17:17
01/04/19
01/04
17:17
01/04/19
17:17
Syndicate
Breaking Syndicate news story on Obalon Therapeutics »

Obalon Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    May

OBLN

Obalon Therapeutics

$2.31

0.24 (11.59%)

07:25
01/03/19
01/03
07:25
01/03/19
07:25
Conference/Events
Obalon Therapeutics to host conference call »

Conference call, to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jan

  • 18

    May

OBLN

Obalon Therapeutics

$2.07

(0.00%)

09:44
01/02/19
01/02
09:44
01/02/19
09:44
Conference/Events
Obalon Therapeutics to host conference call »

Conference call, to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jan

  • 18

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.